4D Molecular Therapeutics
FDMT
FDMT
77 hedge funds and large institutions have $541M invested in 4D Molecular Therapeutics in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $515M → $541M (+$26.4M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
98% less call options, than puts
Call options by funds: $9K | Put options by funds: $495K
Holders
77
Holding in Top 10
2
Calls
$9K
Puts
$495K
Top Buyers
| 1 | +$20.6M | |
| 2 | +$16.8M | |
| 3 | +$15.8M | |
| 4 |
BlackRock
New York
|
+$14.2M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$9M |
Top Sellers
| 1 | -$16.2M | |
| 2 | -$12.3M | |
| 3 | -$10.1M | |
| 4 |
CC
Centiva Capital
New York
|
-$7.22M |
| 5 |
Millennium Management
New York
|
-$4.19M |